Peptide record

TPDB07325

Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity standard
13 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB07325
Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia CAFPdb HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 13-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
ILGKIWKGIKSLF
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C75H123N17O15
ARNDCEQHMPTYV
IK
1502.91
10.84
3
0
7
+3
-0.90
0.746
150.00
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
5500
3.66
1
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
0
E
0
Q
2
G
0
H
3
I
2
L
3
K
0
M
1
F
0
P
1
S
0
T
1
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 2 H: 0 I: 3 L: 2 K: 3 M: 0 F: 1 P: 0 S: 1 T: 0 W: 1 Y: 0 V: 0
Chemical Descriptors
13 reviewed residue count
C75H123N17O15 sequence-only estimate (linear, free termini)
1502.91 sequence-only estimate (linear, free termini)
10.84 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
-0.90 sequence-only estimate (linear, free termini)
0.746 sequence-only estimate (linear, free termini)
Evidence Records 7 records
Evidence 1 Activity

Activity

0% Hemolysis
Toxicity
23.29 µM
Hemolytic Cytotoxic
0% Hemolysis | 23.29 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Anticancer Activities of Antimicrobial BmKn2 Peptides Against Oral and Colon Cancer Cells | Int J Pept Res Ther | 2014
Evidence 2 Activity

Activity

8% Hemolysis
Toxicity
25 µM
Hemolytic Cytotoxic
8% Hemolysis | 25 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antibiotic activity and structural analysis of the scorpion-derived antimicrobial peptide IsCT and its analogs. | Biochem Biophys Res Commun | 2004
Evidence 3 Activity

Activity

50% Hemolysis
Toxicity
100 µM
Hemolytic Cytotoxic
50% Hemolysis | 100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antibiotic activity and structural analysis of the scorpion-derived antimicrobial peptide IsCT and its analogs. | Biochem Biophys Res Commun | 2004
Evidence 4 Activity

Activity

50% Hemolysis
Toxicity
50 µg/mL
Hemolytic Cytotoxic
50% Hemolysis | 50 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antibacterial Activity and Toxicity of Analogs of Scorpion Venom IsCT Peptides. | Antibiotics (Basel) | 2017
Evidence 5 Activity

Activity

65% Hemolysis
Toxicity
100 µg/mL
Hemolytic Cytotoxic
65% Hemolysis | 100 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antibacterial Activity and Toxicity of Analogs of Scorpion Venom IsCT Peptides. | Antibiotics (Basel) | 2017
Evidence 6 Activity

Activity

50% Hemolysis
Toxicity
92.17 µg/mL
Hemolytic Cytotoxic
50% Hemolysis | 92.17 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
An unprecedented alteration in mode of action of IsCT resulting its translocation into bacterial cytoplasm and inhibition of macromolecular syntheses. | Sci Rep | 2015
Evidence 7 Hemolysis

Source & Reference

HemoPI PD_Hemolysis
PD_Hemolysis